Biosimilars Trying to Enter the Ukrainian Market
The past few decades have seen a real breakthrough in the field of biotechnology, which is being increasingly used in various fields, but especially in medicine. Patents for exclusive marketing of a number of original biotech drugs are expected to expire within the next few years. This provides an opportunity for manufacturing and development of biosimilars — official copies, reproduced of biotech medicinal products…
The abstract/extract view of this article is free. Access to the full text of this article requires a subscription.
Please send subscription inquiries by:
Fax: +380 44 495-2777